Contact Us
Add：Building C5, No.9 Weidi Road, Xianlin Street, Qixia District, Nanjing City, Jiangsu Province, China
Tel: 025-5280 5760
Email: market@hanxinpharm.com
About Us
Services
Products
WeChat
Follow Us
Semaglutide CAS：910463-68-2 Molecular Formula： C₁₈₇H₂₉₁N₄₅O₅₉ Purity：>99% (for injection),>98% (for tablets) Application: Used for the treatment of type II diabetes.
Market potential: By 2022, the global sales of Semaglutide preparations will be approximately USD 24.3 billion, in a high-growth phase, with huge development potential. In case any product is still in valid patent, it will not be used for any commercial purpose.
Liraglutide CAS：204656-20-2 Molecular Formula： C₁₇₂H₂₆₅N₄₃O₅₁ Purity：>95%, >99% (two specifications) Application: Used for the treatment of type II diabetes and obesity.
Market Potential: In 2022, the global sales of various specifications of Liraglutide injection were approximately USD 6.7 billion, with huge market capacity and broad prospects. Epinephrine CAS：51-43-4 Molecular Formula：C₉H₁₃NO₃ Purity：>99% Application: Used for severe respiratory distress caused by bronchospasm, cardiac arrest caused by various reasons, and can be used for cardiopulmonary resuscitation. It can also be used to relieve drug-induced anaphylactic shock. Market Potential: In 2022, the global sales of Epinephrine were approximately USD 2.4 billion, with huge market capacity and broad prospects. Norepinephrine Bitartrate CAS：108341-18-0 Molecular Formula：C₈H₁₁NO₃· C₄H₆O₆· H ₂O Purity：>99% Application: Used to treat diseases with sudden drop in bloodpressure, such as cardiogenic shock, anesthesia overdose, hemorrhagic shock, heart failure, toxic shock, and other critical illnesses.
Market Potential: In 2022, the global sales of Norepinephrine Bitartrate were approximately USD 500 million.
Ganirelix Acetate CAS：123246-29-7 Molecular Formula：C₈₀H₁₁₃N₁₈O₁₃Cl·₂CH₃COOH Purity：>99% Application: This product is used in women undergoing controlled ovarian stimulation (COS) in assisted reproductive technology (ART) to prevent early onset of luteinizing hormone (LH) peaks. Market Potential: In 2022, the global sales of Ganirelix Acetate were approximately USD 230 million. |
